Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D McSherry

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|March 21, 2003
Persistent non-gastrointestinal metabolic acidosis in pediatric HIV-1 infectionRana Chakraborty, Constancia S Uy, James M Oleske, et al.
Case Reports in Pediatrics|November 30, 2012
Residual NADPH oxidase activity and isolated lung involvement in x-linked chronic granulomatous diseaseMaria J Gutierrez, George D McSherry, Faoud T Ishmael, et al.
Cell Cycle (Georgetown, Tex.)|August 28, 2007
Non-catalytic function for ATR in the checkpoint responseTroy D McSherry, Ana A Kitazono, Ali Javaheri, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 27, 2009
Development of a directly observed therapy adherence intervention for adolescents with human immunodeficiency virus-1: application of focus group methodology to inform design, feasibility, and acceptabilityPatricia A Garvie, Joanne Lawford, Patricia M Flynn, et al.
Pediatrics|May 1, 1995
Older children and adolescents living with perinatally acquired human immunodeficiency virus infectionS Grubman, E Gross, N Lerner-Weiss, et al.
The Journal of Pediatrics|June 4, 1999
The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076)G D McSherry, D E Shapiro, R W Coombs, et al.
Open Forum Infectious Diseases|August 4, 2019
Customizing an Electronic Medical Record to Automate the Workflow and Tracking of an Antimicrobial Stewardship ProgramMichael Katzman, Jihye Kim, Mark D Lesher, et al.
The Journal of Infectious Diseases|March 14, 1998
Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076P S Eastman, D E Shapiro, R W Coombs, et al.
The Journal of Pediatrics|January 10, 2003
Pharmacokinetics and tolerance of zidovudine in preterm infantsEdmund V Capparelli, Mark Mirochnick, Wayne M Dankner, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 18, 2011
Psychological factors, beliefs about medication, and adherence of youth with human immunodeficiency virus in a multisite directly observed therapy pilot studyPatricia A Garvie, Patricia M Flynn, Marvin Belzer, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|March 21, 2003
Persistent non-gastrointestinal metabolic acidosis in pediatric HIV-1 infectionRana Chakraborty, Constancia S Uy, James M Oleske, et al.
Case Reports in Pediatrics|November 30, 2012
Residual NADPH oxidase activity and isolated lung involvement in x-linked chronic granulomatous diseaseMaria J Gutierrez, George D McSherry, Faoud T Ishmael, et al.
Cell Cycle (Georgetown, Tex.)|August 28, 2007
Non-catalytic function for ATR in the checkpoint responseTroy D McSherry, Ana A Kitazono, Ali Javaheri, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 27, 2009
Development of a directly observed therapy adherence intervention for adolescents with human immunodeficiency virus-1: application of focus group methodology to inform design, feasibility, and acceptabilityPatricia A Garvie, Joanne Lawford, Patricia M Flynn, et al.
Pediatrics|May 1, 1995
Older children and adolescents living with perinatally acquired human immunodeficiency virus infectionS Grubman, E Gross, N Lerner-Weiss, et al.
The Journal of Pediatrics|June 4, 1999
The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076)G D McSherry, D E Shapiro, R W Coombs, et al.
Open Forum Infectious Diseases|August 4, 2019
Customizing an Electronic Medical Record to Automate the Workflow and Tracking of an Antimicrobial Stewardship ProgramMichael Katzman, Jihye Kim, Mark D Lesher, et al.
The Journal of Infectious Diseases|March 14, 1998
Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076P S Eastman, D E Shapiro, R W Coombs, et al.
The Journal of Pediatrics|January 10, 2003
Pharmacokinetics and tolerance of zidovudine in preterm infantsEdmund V Capparelli, Mark Mirochnick, Wayne M Dankner, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 18, 2011
Psychological factors, beliefs about medication, and adherence of youth with human immunodeficiency virus in a multisite directly observed therapy pilot studyPatricia A Garvie, Patricia M Flynn, Marvin Belzer, et al.
Pageof 3